PP01.15: Neoadjuvant Chemo-Immunotherapy versus Chemo-TKI in Resectable EGFR-Mutant NSCLC

Journal of Thoracic Oncology 2026

View at publisher

Authors: Jiefei Han, Yali Wang, Wenbin Li

DOI: 10.1016/j.jtho.2025.12.093

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Radiopharmaceutical Chemistry and Applications Cancer Immunotherapy and Biomarkers